Literature DB >> 25122793

Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.

Ji-Young Lee1, Eliana G Acosta1, Ina Karen Stoeck1, Gang Long1, Marie-Sophie Hiet1, Birthe Mueller2, Oliver T Fackler2, Stephanie Kallis1, Ralf Bartenschlager3.   

Abstract

UNLABELLED: The assembly of infectious hepatitis C virus (HCV) particles is tightly linked to components of the very-low-density lipoprotein (VLDL) pathway. We and others have shown that apolipoprotein E (ApoE) plays a major role in production of infectious HCV particles. However, the mechanism by which ApoE contributes to virion assembly/release and how it gets associated with the HCV particle is poorly understood. We found that knockdown of ApoE reduces titers of infectious intra- and extracellular HCV but not of the related dengue virus. ApoE depletion also reduced amounts of extracellular HCV core protein without affecting intracellular core amounts. Moreover, we found that ApoE depletion affected neither formation of nucleocapsids nor their envelopment, suggesting that ApoE acts at a late step of assembly, such as particle maturation and infectivity. Importantly, we demonstrate that ApoE interacts with the HCV envelope glycoproteins, most notably E2. This interaction did not require any other viral proteins and depended on the transmembrane domain of E2 that also was required for recruitment of HCV envelope glycoproteins to detergent-resistant membrane fractions. These results suggest that ApoE plays an important role in HCV particle maturation, presumably by direct interaction with viral envelope glycoproteins. IMPORTANCE: The HCV replication cycle is tightly linked to host cell lipid pathways and components. This is best illustrated by the dependency of HCV assembly on lipid droplets and the VLDL component ApoE. Although the role of ApoE for production of infectious HCV particles is well established, it is still poorly understood how ApoE contributes to virion formation and how it gets associated with HCV particles. Here, we provide experimental evidence that ApoE likely is required for an intracellular maturation step of HCV particles. Moreover, we demonstrate that ApoE associates with the viral envelope glycoproteins. This interaction appears to be dispensable for envelopment of virus particles but likely contributes to the quality control of secreted infectious virions. These results shed new light on the exploitation of host cell lipid pathways by HCV and the link of viral particle assembly to the VLDL component ApoE.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122793      PMCID: PMC4248909          DOI: 10.1128/JVI.01660-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum.

Authors:  Mike Flint; Jane A McKeating
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

2.  Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain.

Authors:  P Scheiffele; M G Roth; K Simons
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  Characterization of truncated forms of hepatitis C virus glycoproteins.

Authors:  J P Michalak; C Wychowski; A Choukhi; J C Meunier; S Ung; C M Rice; J Dubuisson
Journal:  J Gen Virol       Date:  1997-09       Impact factor: 3.891

4.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

Review 5.  Apolipoprotein E structure: insights into function.

Authors:  Danny M Hatters; Clare A Peters-Libeu; Karl H Weisgraber
Journal:  Trends Biochem Sci       Date:  2006-07-03       Impact factor: 13.807

6.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.

Authors:  M Yanagi; R H Purcell; S U Emerson; J Bukh
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

7.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

8.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Authors:  George Koutsoudakis; Eva Herrmann; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more
  58 in total

1.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Hepatitis C Virus Is Released via a Noncanonical Secretory Route.

Authors:  Karen Bayer; Carina Banning; Volker Bruss; Linda Wiltzer-Bach; Michael Schindler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.

Authors:  Rehab I Moustafa; Juliano G Haddad; Lydia Linna; Xavier Hanoulle; Véronique Descamps; Ahmed Atef Mesalam; Thomas F Baumert; Gilles Duverlie; Philip Meuleman; Jean Dubuisson; Muriel Lavie
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

4.  Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.

Authors:  Zhihua Li; Yadong Li; Yanwei Bi; Hui Zhang; Yufeng Yao; Qihan Li; Wei Cun; Shaozhong Dong
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus.

Authors:  Fabian Elgner; Huimei Ren; Regina Medvedev; Daniela Ploen; Kiyoshi Himmelsbach; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 6.  Chronic hepatitis C virus infection and lipoprotein metabolism.

Authors:  Yoshio Aizawa; Nobuyoshi Seki; Tomohisa Nagano; Hiroshi Abe
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

7.  Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

Authors:  Zaili Yang; Xiaoning Wang; Xiumei Chi; Fanfan Zhao; Jinxu Guo; Pengjuan Ma; Jin Zhong; Junqi Niu; Xiaoyu Pan; Gang Long
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

8.  Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress.

Authors:  Constantin N Takacs; Ursula Andreo; Rachel L Belote; Joan Pulupa; Margaret A Scull; Caroline E Gleason; Charles M Rice; Sanford M Simon
Journal:  Traffic       Date:  2017-01-31       Impact factor: 6.215

9.  Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.

Authors:  Francesc Puig-Basagoiti; Takasuke Fukuhara; Tomokazu Tamura; Chikako Ono; Kentaro Uemura; Yukako Kawachi; Satomi Yamamoto; Hiroyuki Mori; Takeshi Kurihara; Toru Okamoto; Hideki Aizaki; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Authors:  Sara Calattini; Floriane Fusil; Jimmy Mancip; Viet Loan Dao Thi; Christelle Granier; Nicolas Gadot; Jean-Yves Scoazec; Mirjam B Zeisel; Thomas F Baumert; Dimitri Lavillette; Marlène Dreux; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.